EW
Edwards Lifesciences·NYSE
--
--(--)
--
--(--)
EW fundamentals
Edwards Lifesciences (EW) released its earnings on Feb 10, 2026: revenue was 1.57B (YoY +13.26%), beat estimates; EPS was 0.58 (YoY -1.69%), missed estimates.
Revenue / YoY
1.57B
+13.26%
EPS / YoY
0.58
-1.69%
Report date
Feb 10, 2026
EW Earnings Call Summary for Q4,2025
- Record Growth: 11.6% Q4 and 10.7% full-year revenue growth, driven by TAVR (10.6% YoY), TMTT (40% Q4), and Surgical ($1B+ annual sales).
- TAVR Leadership: SAPIEN platform gains share amid competitor exit, with 7-year PARTNER III and 10-year PARTNER II data reinforcing long-term durability. Q4 procedural growth in high single digits globally.
- TMTT Expansion: $500M+ annual TMTT sales, with PASCAL, EVOQUE, and SAPIEN M3 driving mitral/tricuspid repair/replacement growth. Targeting $2B+ by 2030.
- Financial Confidence: 2026 guidance reaffirmed (8-10% sales growth, $2.90-3.05 EPS), with 78-79% gross margin and 16-19% tax rate.
- Strategic Initiatives: $112M Q4 SG&A investment in patient access, LAA launch late 2026, and PROGRESS trial results expected at TCT.
Earnings
EPS
Revenue
Revenue & Expenses
EW has released its 2025 Q4 earnings report, with revenue of 1.57B, reflecting a YoY change of 13.26%, and net profit of 91.20M, showing a YoY change of -76.27%. The Sankey diagram below clearly presents EW's revenue sources and cost distribution.
Key Indicators
Edwards Lifesciences (EW) key financial stats and ratios, covering profitability, financial health, and leverage.
Income Statement
Edwards Lifesciences (EW)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Balance Sheet
Edwards Lifesciences (EW)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Cash Flow
Edwards Lifesciences (EW)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Revenue Breakdown
Where does Edwards Lifesciences (EW) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Dividend
Track Edwards Lifesciences (EW) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
Did Edwards Lifesciences beat or miss consensus estimates last quarter?What were the key takeaways from Edwards Lifesciences's earnings call?What does Edwards Lifesciences do and what are its main business segments?What were the key takeaways from Edwards Lifesciences’s earnings call?What is Edwards Lifesciences's latest dividend and current dividend yield?What factors drove the changes in Edwards Lifesciences's revenue and profit?What is the market's earnings forecast for Edwards Lifesciences next quarter?What guidance did Edwards Lifesciences's management provide for the next earnings period?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
